The Board granted an initial 60 percent rating for left cheek lichen simplex chronicus but denied a separate compensable rating for the left cheek scar.
The deciding factor: The evidence demonstrated that the Veteran's left cheek condition required constant or near-constant systemic therapy, such as corticosteroids or other immunosuppressive drugs, which warranted a 60 percent rating under Diagnostic Code 7822. However, an award of a separate compensable rating for the left cheek scar would violate the rule against pyramiding.
- Claimed conditions
- left cheek lichen simplex chronicus, left cheek scar
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- December 11, 2025
- Citation
- A25107409
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.